PN MEDICAL, INC.
ORLANDO, FLORIDA

PN Medical, Inc. is a Florida-based company committed to improving people's lives by aiding respiratory health through innovative devices like the Breather II. Founded on February 19, 2015, the company has been steadfast in its mission 'to help them breathe better,' promising enhanced quality of life for individuals facing various respiratory challenges. Located at 225 S Swope Ave, Suite 215, Maitland, FL, PN Medical incorporates feedback from global healthcare professionals and patients to guide its product development. PN Medical's flagship device, the Breather, offers Respiratory Muscle Training (RMT) that proves essential for individuals experiencing dyspnea or activity intolerance due to conditions like COPD. Research substantiates RMT as more effective than physical exercise alone in improving inspiratory muscle strength and endurance among COPD patients. The Breather also aids children with muscular dystrophies by reducing perceived respiratory effort, supports those with spinal cord injuries during the acute phase through enhanced cough function, and offers athletes with chronic SCI improved exercise performance and lung capacity. Respiratory muscle training mitigates comorbidity symptoms in conditions like COPD combined with cardiovascular issues or asthma. Furthermore, in palliative care settings, RMT helps improve airway clearance, reduce pneumonia risk, and combat depression, enhancing overall quality of life for patients with severe illnesses such as pulmonary fibrosis and lung cancer. PN Medical emphasizes patient impact through testimonials, reflecting personal improvements in lung capacity and breathing technique post-surgeries. The company is registered under the state of Florida as a Domestic Non-Profit Corporation (DOMP) and maintains its corporate status with filings like 'AMENDED AND RESTATED ARTICLES' dated November 9, 2015, and the latest annual report filed on April 19, 2024. Leadership at PN Medical is spearheaded by key figures such as Mark Carbone, the Chief Executive Officer, alongside Directors Susan Carbone and Marguerite K Nicholson. The company prioritizes stakeholder involvement in its innovative pursuits and continues to provide a holistic approach to respiratory health management worldwide.